Sales Support:
sales@worldwidemarketreports.com
U.S. :+1 415 871 0703
U.K. :+44-203-289-4040
AUS. : +61-2-4786-0457
INDIA :+91-848-285-0837
Menu Icon Close Icon
We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.

Global mRNA Vaccines & Therapeutics Market Analysis 2016-2020 and Forecast 2021-2026

  • Report Code : 664138
  • Industry : Medical Devices
  • Published On : Mar 2021
  • Pages : 112
  • Publisher : 99strategy
  • Format: WMR PPT FormatWMR PDF Format

Snapshot

The global mRNA Vaccines & Therapeutics market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of mRNA Vaccines & Therapeutics by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Argos Therapeutics
AstraZeneca
Bayer
BioNTech
Boehringer Ingelheim
CRISPR Therapeutics
CureVac
eTheRNA immunotherapies
Ethris
GlaxoSmithKline Vaccines
In-Cell-Art
Intellia Therapeutics
Janssen
Kernal Biologics
MaxCyte
Moderna Therapeutics
Novartis
PhaseRx
Precision NanoSystems
RaNa Therapeutics

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospital
Clinic
Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)

Table of Contents
1 Industry Overview
1.1 mRNA Vaccines & Therapeutics Industry
Figure mRNA Vaccines & Therapeutics Industry Chain Structure
1.1.1 Overview
1.1.2 Development of mRNA Vaccines & Therapeutics
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of mRNA Vaccines & Therapeutics
1.2.2 Downstream
Table Application Segment of mRNA Vaccines & Therapeutics
Table Global mRNA Vaccines & Therapeutics Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 mRNA Vaccines & Therapeutics Market by Type
3.1 By Type
3.1.1 Standardization Of Cancer Treatment MRNA Vaccine
Table Major Company List of Standardization Of Cancer Treatment MRNA Vaccine
3.1.2 Individualized Cancer Treatment MRNA Vaccine
Table Major Company List of Individualized Cancer Treatment MRNA Vaccine
3.1.3 Infectious Disease Treatment MRNA Vaccine
Table Major Company List of Infectious Disease Treatment MRNA Vaccine
3.1.4 Infection Prevention MRNA Vaccine
Table Major Company List of Infection Prevention MRNA Vaccine
3.2 Market Size
Table Global mRNA Vaccines & Therapeutics Market 2016-2020, by Type, in USD Million
Figure Global mRNA Vaccines & Therapeutics Market Growth 2016-2020, by Type, in USD Million
Table Global mRNA Vaccines & Therapeutics Market 2016-2020, by Type, in Volume
Figure Global mRNA Vaccines & Therapeutics Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global mRNA Vaccines & Therapeutics Market Forecast 2021-2026, by Type, in USD Million
Table Global mRNA Vaccines & Therapeutics Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Argos Therapeutics (Company Profile, Sales Data etc.)
4.1.1 Argos Therapeutics Profile
Table Argos Therapeutics Overview List
4.1.2 Argos Therapeutics Products & Services
4.1.3 Argos Therapeutics Business Operation Conditions
Table Business Operation of Argos Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 AstraZeneca (Company Profile, Sales Data etc.)
4.2.1 AstraZeneca Profile
Table AstraZeneca Overview List
4.2.2 AstraZeneca Products & Services
4.2.3 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Bayer (Company Profile, Sales Data etc.)
4.3.1 Bayer Profile
Table Bayer Overview List
4.3.2 Bayer Products & Services
4.3.3 Bayer Business Operation Conditions
Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 BioNTech (Company Profile, Sales Data etc.)
4.4.1 BioNTech Profile
Table BioNTech Overview List
4.4.2 BioNTech Products & Services
4.4.3 BioNTech Business Operation Conditions
Table Business Operation of BioNTech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Boehringer Ingelheim (Company Profile, Sales Data etc.)
4.5.1 Boehringer Ingelheim Profile
Table Boehringer Ingelheim Overview List
4.5.2 Boehringer Ingelheim Products & Services
4.5.3 Boehringer Ingelheim Business Operation Conditions
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 CRISPR Therapeutics (Company Profile, Sales Data etc.)
4.6.1 CRISPR Therapeutics Profile
Table CRISPR Therapeutics Overview List
4.6.2 CRISPR Therapeutics Products & Services
4.6.3 CRISPR Therapeutics Business Operation Conditions
Table Business Operation of CRISPR Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 CureVac (Company Profile, Sales Data etc.)
4.7.1 CureVac Profile
Table CureVac Overview List
4.7.2 CureVac Products & Services
4.7.3 CureVac Business Operation Conditions
Table Business Operation of CureVac (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 eTheRNA immunotherapies (Company Profile, Sales Data etc.)
4.8.1 eTheRNA immunotherapies Profile
Table eTheRNA immunotherapies Overview List
4.8.2 eTheRNA immunotherapies Products & Services
4.8.3 eTheRNA immunotherapies Business Operation Conditions
Table Business Operation of eTheRNA immunotherapies (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Ethris (Company Profile, Sales Data etc.)
4.9.1 Ethris Profile
Table Ethris Overview List
4.9.2 Ethris Products & Services
4.9.3 Ethris Business Operation Conditions
Table Business Operation of Ethris (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 GlaxoSmithKline Vaccines (Company Profile, Sales Data etc.)
4.10.1 GlaxoSmithKline Vaccines Profile
Table GlaxoSmithKline Vaccines Overview List
4.10.2 GlaxoSmithKline Vaccines Products & Services
4.10.3 GlaxoSmithKline Vaccines Business Operation Conditions
Table Business Operation of GlaxoSmithKline Vaccines (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 In-Cell-Art (Company Profile, Sales Data etc.)
4.11.1 In-Cell-Art Profile
Table In-Cell-Art Overview List
4.11.2 In-Cell-Art Products & Services
4.11.3 In-Cell-Art Business Operation Conditions
Table Business Operation of In-Cell-Art (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Intellia Therapeutics (Company Profile, Sales Data etc.)
4.12.1 Intellia Therapeutics Profile
Table Intellia Therapeutics Overview List
4.12.2 Intellia Therapeutics Products & Services
4.12.3 Intellia Therapeutics Business Operation Conditions
Table Business Operation of Intellia Therapeutics (Sales Revenue, Cost, Gross Margin)
4.13 Janssen (Company Profile, Sales Data etc.)
4.13.1 Janssen Profile
Table Janssen Overview List
4.13.2 Janssen Products & Services
4.13.3 Janssen Business Operation Conditions
Table Business Operation of Janssen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Kernal Biologics (Company Profile, Sales Data etc.)
4.14.1 Kernal Biologics Profile
Table Kernal Biologics Overview List
4.14.2 Kernal Biologics Products & Services
4.14.3 Kernal Biologics Business Operation Conditions
Table Business Operation of Kernal Biologics (Sales Revenue, Cost, Gross Margin)
4.15 MaxCyte (Company Profile, Sales Data etc.)
4.15.1 MaxCyte Profile
Table MaxCyte Overview List
4.15.2 MaxCyte Products & Services
4.15.3 MaxCyte Business Operation Conditions
Table Business Operation of MaxCyte (Sales Revenue, Cost, Gross Margin)
4.16 Moderna Therapeutics (Company Profile, Sales Data etc.)
4.16.1 Moderna Therapeutics Profile
Table Moderna Therapeutics Overview List
4.16.2 Moderna Therapeutics Products & Services
4.16.3 Moderna Therapeutics Business Operation Conditions
Table Business Operation of Moderna Therapeutics (Sales Revenue, Cost, Gross Margin)
4.17 Novartis (Company Profile, Sales Data etc.)
4.17.1 Novartis Profile
Table Novartis Overview List
4.17.2 Novartis Products & Services
4.17.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Cost, Gross Margin)
4.18 PhaseRx (Company Profile, Sales Data etc.)
4.18.1 PhaseRx Profile
Table PhaseRx Overview List
4.18.2 PhaseRx Products & Services
4.18.3 PhaseRx Business Operation Conditions
Table Business Operation of PhaseRx (Sales Revenue, Cost, Gross Margin)
4.19 Precision NanoSystems (Company Profile, Sales Data etc.)
4.19.1 Precision NanoSystems Profile
Table Precision NanoSystems Overview List
4.19.2 Precision NanoSystems Products & Services
4.19.3 Precision NanoSystems Business Operation Conditions
Table Business Operation of Precision NanoSystems (Sales Revenue, Cost, Gross Margin)
4.20 RaNa Therapeutics (Company Profile, Sales Data etc.)
4.20.1 RaNa Therapeutics Profile
Table RaNa Therapeutics Overview List
4.20.2 RaNa Therapeutics Products & Services
4.20.3 RaNa Therapeutics Business Operation Conditions
Table Business Operation of RaNa Therapeutics (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global mRNA Vaccines & Therapeutics Sales Revenue 2016-2020, by Company, in USD Million
Table Global mRNA Vaccines & Therapeutics Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global mRNA Vaccines & Therapeutics Sales Revenue Share in 2020, by Company, in USD Million
Table Global mRNA Vaccines & Therapeutics Sales Volume 2016-2020, by Company, in Volume
Table Global mRNA Vaccines & Therapeutics Sales Volume Share 2016-2020, by Company, in Volume
Figure Global mRNA Vaccines & Therapeutics Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America mRNA Vaccines & Therapeutics Market Concentration, in 2020
Figure Europe mRNA Vaccines & Therapeutics Market Market Concentration, in 2020
Figure Asia-Pacific mRNA Vaccines & Therapeutics MMarket Concentration, in 2020
Figure South America mRNA Vaccines & Therapeutics Market Concentration, in 2020
Figure Middle East & Africa mRNA Vaccines & Therapeutics Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital
Figure mRNA Vaccines & Therapeutics Demand in Hospital, 2016-2020, in USD Million
Figure mRNA Vaccines & Therapeutics Demand in Hospital, 2016-2020, in Volume
6.1.2 Demand in Clinic
Figure mRNA Vaccines & Therapeutics Demand in Clinic, 2016-2020, in USD Million
Figure mRNA Vaccines & Therapeutics Demand in Clinic, 2016-2020, in Volume
6.1.3 Demand in Others
Figure mRNA Vaccines & Therapeutics Demand in Others, 2016-2020, in USD Million
Figure mRNA Vaccines & Therapeutics Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table mRNA Vaccines & Therapeutics Demand Forecast 2021-2026, by Application, in USD Million
Figure mRNA Vaccines & Therapeutics Market Growth 2021-2026, by Application, in USD Million
Figure mRNA Vaccines & Therapeutics Market Share in 2026, by Application, in USD Million
Table mRNA Vaccines & Therapeutics Demand Forecast 2021-2026, by Application, in Volume
Table mRNA Vaccines & Therapeutics Market Growth 2021-2026, by Application, in Volume
Table mRNA Vaccines & Therapeutics Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table mRNA Vaccines & Therapeutics Production 2016-2020, by Region, in USD Million
Table mRNA Vaccines & Therapeutics Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global mRNA Vaccines & Therapeutics Market 2016-2020, by Region, in USD Million
Table Global mRNA Vaccines & Therapeutics Market Share 2016-2020, by Region, in USD Million
Table Global mRNA Vaccines & Therapeutics Market 2016-2020, by Region, in Volume
Table Global mRNA Vaccines & Therapeutics Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure North America mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
Table North America mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure Europe mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
Table Europe mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure South America mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
Table South America mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table mRNA Vaccines & Therapeutics Market Forecast 2021-2026, by Region, in USD Million
Table mRNA Vaccines & Therapeutics Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

List of Table
1. Table Upstream Segment of mRNA Vaccines & Therapeutics
2. Table Application Segment of mRNA Vaccines & Therapeutics
3. Table Global mRNA Vaccines & Therapeutics Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Individualized Cancer Treatment MRNA Vaccine
5. Table Major Company List of Infectious Disease Treatment MRNA Vaccine
6. Table Major Company List of Infection Prevention MRNA Vaccine
7. Table Global mRNA Vaccines & Therapeutics Market 2016-2020, by Type, in USD Million
8. Table Global mRNA Vaccines & Therapeutics Market 2016-2020, by Type, in Volume
9. Table Global mRNA Vaccines & Therapeutics Market Forecast 2021-2026, by Type, in USD Million
10. Table Global mRNA Vaccines & Therapeutics Market Forecast 2021-2026, by Type, in Volume
11. Table Argos Therapeutics Overview List
12. Table Business Operation of Argos Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
13. Table AstraZeneca Overview List
14. Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
15. Table Bayer Overview List
16. Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
17. Table BioNTech Overview List
18. Table Business Operation of BioNTech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
19. Table Boehringer Ingelheim Overview List
20. Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
21. Table CRISPR Therapeutics Overview List
22. Table Business Operation of CRISPR Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
23. Table CureVac Overview List
24. Table Business Operation of CureVac (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
25. Table eTheRNA immunotherapies Overview List
26. Table Business Operation of eTheRNA immunotherapies (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
27. Table Ethris Overview List
28. Table Business Operation of Ethris (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
29. Table GlaxoSmithKline Vaccines Overview List
30. Table Business Operation of GlaxoSmithKline Vaccines (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
31. Table In-Cell-Art Overview List
32. Table Business Operation of In-Cell-Art (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
33. Table Intellia Therapeutics Overview List
34. Table Business Operation of Intellia Therapeutics (Sales Revenue, Cost, Gross Margin)
35. Table Janssen Overview List
36. Table Business Operation of Janssen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
37. Table Kernal Biologics Overview List
38. Table Business Operation of Kernal Biologics (Sales Revenue, Cost, Gross Margin)
39. Table MaxCyte Overview List
40. Table Business Operation of MaxCyte (Sales Revenue, Cost, Gross Margin)
41. Table Moderna Therapeutics Overview List
42. Table Business Operation of Moderna Therapeutics (Sales Revenue, Cost, Gross Margin)
43. Table Novartis Overview List
44. Table Business Operation of Novartis (Sales Revenue, Cost, Gross Margin)
45. Table PhaseRx Overview List
46. Table Business Operation of PhaseRx (Sales Revenue, Cost, Gross Margin)
47. Table Precision NanoSystems Overview List
48. Table Business Operation of Precision NanoSystems (Sales Revenue, Cost, Gross Margin)
49. Table RaNa Therapeutics Overview List
50. Table Business Operation of RaNa Therapeutics (Sales Revenue, Cost, Gross Margin)
51. Table Global mRNA Vaccines & Therapeutics Sales Revenue 2016-2020, by Company, in USD Million
52. Table Global mRNA Vaccines & Therapeutics Sales Revenue Share 2016-2020, by Company, in USD Million
53. Table Global mRNA Vaccines & Therapeutics Sales Volume 2016-2020, by Company, in Volume
54. Table Global mRNA Vaccines & Therapeutics Sales Volume Share 2016-2020, by Company, in Volume
55. Table Regional Demand Comparison List
56. Table Major Application in Different Regions
57. Table mRNA Vaccines & Therapeutics Demand Forecast 2021-2026, by Application, in USD Million
58. Table mRNA Vaccines & Therapeutics Demand Forecast 2021-2026, by Application, in Volume
59. Table mRNA Vaccines & Therapeutics Market Growth 2021-2026, by Application, in Volume
60. Table mRNA Vaccines & Therapeutics Market Share in 2026, by Application, in Volume
61. Table mRNA Vaccines & Therapeutics Production 2016-2020, by Region, in USD Million
62. Table mRNA Vaccines & Therapeutics Production 2016-2020, by Region, in Volume
63. Table Global mRNA Vaccines & Therapeutics Market 2016-2020, by Region, in USD Million
64. Table Global mRNA Vaccines & Therapeutics Market Share 2016-2020, by Region, in USD Million
65. Table Global mRNA Vaccines & Therapeutics Market 2016-2020, by Region, in Volume
66. Table Global mRNA Vaccines & Therapeutics Market Share 2016-2020, by Region, in Volume
67. Table North America mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
68. Table North America mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
69. Table Europe mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
70. Table Europe mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
71. Table Asia-Pacific mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
72. Table Asia-Pacific mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
73. Table South America mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
74. Table South America mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
75. Table Middle East & Africa mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
76. Table Middle East & Africa mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
77. Table mRNA Vaccines & Therapeutics Market Forecast 2021-2026, by Region, in USD Million
78. Table mRNA Vaccines & Therapeutics Market Forecast 2021-2026, by Region, in Volume
79. Table Price Factors List

List of Figure
1. Figure mRNA Vaccines & Therapeutics Industry Chain Structure
2. Figure Global mRNA Vaccines & Therapeutics Market Growth 2016-2020, by Type, in USD Million
3. Figure Global mRNA Vaccines & Therapeutics Market Growth 2016-2020, by Type, in Volume
4. Figure Global mRNA Vaccines & Therapeutics Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global mRNA Vaccines & Therapeutics Sales Volume Share in 2020, by Company, in Volume
6. Figure North America mRNA Vaccines & Therapeutics Market Concentration, in 2020
7. Figure Europe mRNA Vaccines & Therapeutics Market Market Concentration, in 2020
8. Figure Asia-Pacific mRNA Vaccines & Therapeutics MMarket Concentration, in 2020
9. Figure South America mRNA Vaccines & Therapeutics Market Concentration, in 2020
10. Figure Middle East & Africa mRNA Vaccines & Therapeutics Market Concentration, in 2020
11. Figure mRNA Vaccines & Therapeutics Demand in Hospital, 2016-2020, in USD Million
12. Figure mRNA Vaccines & Therapeutics Demand in Hospital, 2016-2020, in Volume
13. Figure mRNA Vaccines & Therapeutics Demand in Clinic, 2016-2020, in USD Million
14. Figure mRNA Vaccines & Therapeutics Demand in Clinic, 2016-2020, in Volume
15. Figure mRNA Vaccines & Therapeutics Demand in Others, 2016-2020, in USD Million
16. Figure mRNA Vaccines & Therapeutics Demand in Others, 2016-2020, in Volume
17. Figure mRNA Vaccines & Therapeutics Market Growth 2021-2026, by Application, in USD Million
18. Figure mRNA Vaccines & Therapeutics Market Share in 2026, by Application, in USD Million
19. Figure North America mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
20. Figure North America mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
21. Figure Europe mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
22. Figure Europe mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
23. Figure Asia-Pacific mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
24. Figure Asia-Pacific mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
25. Figure South America mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
26. Figure South America mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
27. Figure Middle East & Africa mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
28. Figure Middle East & Africa mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
29. Figure Marketing Channels Overview
Healthcare and Pharmaceuticals

Asia Pacific Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034.

  Price : US$ 3450   Date : Oct 2024
  Category : Healthcare and Pharmaceuticals   Pages : 191
Healthcare and Pharmaceuticals

Europe Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034.

  Price : US$ 3450   Date : Oct 2024
  Category : Healthcare and Pharmaceuticals   Pages : 196
Healthcare and Pharmaceuticals

North America Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034.

  Price : US$ 3450   Date : Oct 2024
  Category : Healthcare and Pharmaceuticals   Pages : 194
Healthcare and Pharmaceuticals

Global Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034.

  Price : US$ 3750   Date : Oct 2024
  Category : Healthcare and Pharmaceuticals   Pages : 205
Healthcare and Pharmaceuticals

mRNA Vaccine Drugs Development Services Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)

  Price : US$ 3500   Date : Oct 2024
  Category : Healthcare and Pharmaceuticals   Pages : 132

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
  • Types
  • Applications
  • Technology
  • End-use Industries
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers and restraints
  • Regulatory scenario
  • Industry trend
  • Pestle analysis
  • Porter’s analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Competitive landscape
It helps the businesses in making strategic decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.

Related Reports

Asia Pacific Nuclear Medicine Market Size, Share, Trends & Analysis By Product (Diagnostics (SP...
View More
Europe Nuclear Medicine Market Size, Share, Trends & Analysis By Product (Diagnostics (SPECT, P...
View More
North America Nuclear Medicine Market Size, Share, Trends & Analysis By Product (Diagnostics (S...
View More
Global Nuclear Medicine Market Size, Share, Trends & Analysis By Product (Diagnostics (SPECT, P...
View More
MRNA Vaccine Drugs Development Services Market Size And Share Analysis - Growth Trends And Fore...
View More

Trusted Clients
A-T- Kearney.png
AbbVie.png
Agrinos.png
AIF-Metrics.png
Akzo-Nobel.jpg
Alfi-GMBH.png
Allergan.png
Almasra-Scientific-Bureau.jpg
ALPMA.jpg
Americana-Foods.png
ANP.png
Aptar-Group-Germany.jpg
asahi-kasei.png
ATC.png
atlas-servair.jpg
ATOS.png
Avalon.png
biofishency.png
biomx.png
borealisgroup.png
Cape-Peninsula.png
CBRE.png
Cennerv-Pharma.jpg
Clearponds.png
Compass-Group.png
Cortag-Industria.png
Covis-Pharma.jpg
DAIMLER-AG.jpg
Edipresse-Media.jpg
Epson.png
Evonik-Industries-AG.png
ExcelSource.png
Fingo.png
Firstkind.png
FLM-Foodingredients.png
Freudenberg.png
Fueltrax.jpg
Fugro-International.png
Fuji-Films.png
Funky-Sound-Studio.png
GALTWAY.png
Gartner.png
GBSC.png
Global-Information.jpg
Hanwha-Total-Petrochemical.png
Hebrew.png
Horiba-Mira.png
Hunter-and-Co-Investments.png
Hyosung.png
Hyssopus-Organics.jpg
IBSA.png
Ideagen.png
IMS.png
InSinkErator.png
Intas-Pharma.png
IntelMed-Sarl.png
Interdiligence-Consulting.png
Israel-Shopyards.png
Johnsons-Controls.png
kakaxi.jpg
KORDSA.png
kotra.png
KPMG.png
lantmannen.png
LEK.png
LG.jpg
Makuri-Technology.jpg
Mallinckrodt.png
Mappo.png
Maprimed.jpg
mcns.jpg
MED-EL.png
Mehr-Azin-Pouya-Sahand.png
Molkerei-Ammerland-eG.png
Monty-Holding.jpg
mpmaterials.png
Mundipharma.png
Nasco.png
Nitto.png
Nouryon.png
NOXTAK.png
Oskars.png
Paidotribo.png
Parnell-Pharmaceuticals.png
Podravka.png
ppg.png
Privi.png
Publicis Groupe.png
Qvetech.jpg
R3P.jpg
Samsung.png
Sapient.png
SEW-EURODRIVE.png
Shivananda.jpg
Silver-Clouds.png
SMIT.jpg
SOLVIAS.png
Spectrum.png
SR-Instruments-Oy.png
Star-Seed.png
Stryker -ENT.png
Synjenta.png
Terumo-Corp.png
TherOzone.png
Toshiba.png
TT-Electronics.png
umbc.edu.png
Vard.jpg
Vital-Xense.png
Walraven.png
Wlgore.png
Woodmac.png
WWF-UK.png
ZENOAQ.png
Zuellig-Pharma.png
Contact us

sales@worldwidemarketreports.com

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

phoneiconU.S. : +1 415 871 0703

phoneiconU.K. : +44-203-289-4040

phoneiconAUS. :+61-2-4786-0457

phoneiconIndia :+91-848-285-0837

Menu
Quick Links
Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved